BY Maria Outze
-
Leo Pharma is one step closer to its 2025-goal – CEO sees no obstacles on the road to the stock market
Leo Pharma published a revenue of DKK 235m (USD 36.79 m) in the 2nd quarter of 2025. This follows a number of years of considerable losses.
-
Lundbeck is in the process of its largest capital restructuring: “I want to avoid the word ‘cuts’”
Lundbeck chief executive officer refutes that there have actually been discharges about the firm’s considerable reallocation of sources.
-
New Trump law exempts orphan drugs from price negotiations
This additionally puts on the supposed smash hit medicines with a number of uncommon indicators.
-
Obesity drug demand is soaring in India following Wegovy launch
The excessive weight market in India has actually expanded fivefold considering that 2021, reports information company Reuters.
-
Novo Nordisk tops advertising list: Spent millions on Wegovy ads
In June, Novo Nordisk’s Wegovy rated leading on the checklist of one of the most pricey medications promoted on United States TELEVISION. Lundbeck is likewise on the checklis…
-
WHO to copy Danish model: “Denmark is recognized as a frontrunner”
The that has actually simply authorized a memorandum of comprehending with Danish Life Scientific research Collection to assist advertise public-private collaborations in European …
-
Biotech boss calls for global vision in EU life science strategy: “Let’s learn from those who are ahead”
Absence of accessibility to resources is the “overriding trouble” for European biotech firms, and brand-new EU approach stops working to supply services, according to a…
-
New strategy to make EU a world leader in life sciences – industry players lack concrete action
A number of essential life scientific research gamers are thrilled that a European life scientific research method is currently in position. Nonetheless, it does not have extra con…
-
Top execs push EU politicians to include gene therapy in biotech act
It is anticipated that the extensive legal bundle for the biotech industry, the Biotech Act, will certainly exist in 2026.
-
Universal Robots Launches UR Studio – A New Online Simulation Tool Making It Simpler Than Ever to Customize the Optimal Robot Cell | RoboticsTomorrow
In style Robots Launches UR Studio – A New On-line Simulation Gadget Making It More effective Than Ever to Customise the Optimal Robot Cell With UR Studio, users can test robotic movements, simulate attain, prance and workflow, and calculate cycle time, making it one of the best technique to configure an optimized cell, maximizing return